These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8643101)

  • 1. Dependence of the murine antibody response to an anti-CDR2 VH peptide on immunogen formulation.
    Kanda P; Fritz DA; Gage DA; Shuler KR
    Mol Immunol; 1995 Dec; 32(17-18):1319-28. PubMed ID: 8643101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-CD4.
    Attanasio R; Kanda P; Stunz GW; Buck DW; Kennedy RC
    Mol Immunol; 1993 Jan; 30(1):9-17. PubMed ID: 8417378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to a CD4 peptide derivative which includes the region corresponding to an immunoglobulin CDR3: evidence of the involvement of pre-CDR3-related region in HIV-1 and host cell interaction.
    Ohki K; Kimura T; Ohmura K; Morikawa Y; Jones IM; Azuma I; Ikuta K
    Mol Immunol; 1992 Nov; 29(11):1391-400. PubMed ID: 1406723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1-->6) dextran antibody.
    Coloma MJ; Trinh RK; Martinez AR; Morrison SL
    J Immunol; 1999 Feb; 162(4):2162-70. PubMed ID: 9973491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-idiotypic antibodies of a predefined specificity generated against CDR3VH synthetic peptides define a private anti-CD4 idiotype.
    Attanasio R; Kennedy RC; Allan JS; Maino VC; Buck D; Kanda P
    Mol Immunol; 1990 Jun; 27(6):513-22. PubMed ID: 2116595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells.
    Ward FJ; Khan N; Wolger LJ; Howe CA; Eivazova ER; Harper N; Muller S; Staines NA
    J Autoimmun; 1998 Oct; 11(5):439-47. PubMed ID: 9802927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
    Wiens GD; Heldwein KA; Stenzel-Poore MP; Rittenberg MB
    J Immunol; 1997 Aug; 159(3):1293-302. PubMed ID: 9233625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice.
    Brosh N; Dayan M; Fridkin M; Mozes E
    Immunol Lett; 2000 Apr; 72(1):61-8. PubMed ID: 10789683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular localization of human IgG anti-F(ab')2 reactivity with variable- and constant-region lambda light-chain epitopes.
    Williams RC; Malone CC; Silvestris F; Solomon A
    J Clin Immunol; 1995 Nov; 15(6):349-62. PubMed ID: 8576321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-peptide antibodies detect a lupus-related interspecies idiotype that maps to H chain CDR2.
    Meek K; Takei M; Dang H; Sanz I; Dauphinée MJ; Capra JD; Talal N
    J Immunol; 1990 Feb; 144(4):1375-81. PubMed ID: 1689352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths.
    Shan D; Press OW; Tsu TT; Hayden MS; Ledbetter JA
    J Immunol; 1999 Jun; 162(11):6589-95. PubMed ID: 10352275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
    Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
    J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.
    Ichiyoshi Y; Casali P
    J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.
    Zimmerman DH; Lloyd JP; Heisey D; Winship MD; Siwek M; Talor E; Sarin PS
    Vaccine; 2001 Sep; 19(32):4750-9. PubMed ID: 11535326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of an anti-DNA-associated VH gene in immunized and autoimmune mice.
    Ash-Lerner A; Ginsberg-Strauss M; Pewzner-Jung Y; Desai DD; Marion TN; Eilat D
    J Immunol; 1997 Aug; 159(3):1508-19. PubMed ID: 9233650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG.
    Reitan SK; Hannestad K
    Eur J Immunol; 1995 Jun; 25(6):1601-8. PubMed ID: 7614988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the autoantibody response in peptide-induced autoimmunity.
    Putterman C; Deocharan B; Diamond B
    J Immunol; 2000 Mar; 164(5):2542-9. PubMed ID: 10679092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.
    Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O
    Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of a synthetic peptide derived from an antibody complementarity determining region to phosphatidylserine.
    Igarashi K; Asai K; Kaneda M; Umeda M; Inoue K
    J Biochem; 1995 Feb; 117(2):452-7. PubMed ID: 7608138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.